203 related articles for article (PubMed ID: 35809795)
1. The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis.
Mukherjee AG; Wanjari UR; Bradu P; Murali R; Kannampuzha S; Loganathan T; C GPD; Prakash B P A; Renu K; Dey A; Vellingiri B; Valsala Gopalakrishnan A
Crit Rev Oncol Hematol; 2022 Aug; 176():103757. PubMed ID: 35809795
[TBL] [Abstract][Full Text] [Related]
2. Untapped "-omics": the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment.
Komorowski AS; Pezo RC
Breast Cancer Res Treat; 2020 Jan; 179(2):287-300. PubMed ID: 31646389
[TBL] [Abstract][Full Text] [Related]
3. Integrated multi-omic analyses provide insight into colon adenoma susceptibility modulation by the gut microbiota.
Busi SB; Lei Z; Sumner LW; Amos-Landgraf JM
mSystems; 2023 Aug; 8(4):e0015123. PubMed ID: 37458451
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Role of Gut Microbiome in Colon Cancer.
Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
[TBL] [Abstract][Full Text] [Related]
5. Exploring the human microbiome - A step forward for precision medicine in breast cancer.
Jotshi A; Sukla KK; Haque MM; Bose C; Varma B; Koppiker CB; Joshi S; Mishra R
Cancer Rep (Hoboken); 2023 Nov; 6(11):e1877. PubMed ID: 37539732
[TBL] [Abstract][Full Text] [Related]
6. Annexin-A1 deficiency attenuates stress-induced tumor growth
Cui J; Sachaphibulkij K; Teo WS; Lim HM; Zou L; Ong CN; Alberts R; Chen J; Lim LHK
Theranostics; 2022; 12(8):3794-3817. PubMed ID: 35664067
[No Abstract] [Full Text] [Related]
7. Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.
Malla RR
Crit Rev Oncog; 2020; 25(2):129-139. PubMed ID: 33389862
[TBL] [Abstract][Full Text] [Related]
8. Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers.
Zidi O; Souai N; Raies H; Ben Ayed F; Mezlini A; Mezrioui S; Tranchida F; Sabatier JM; Mosbah A; Cherif A; Shintu L; Kouidhi S
Molecules; 2021 Apr; 26(8):. PubMed ID: 33919750
[TBL] [Abstract][Full Text] [Related]
9. Metabolome of human gut microbiome is predictive of host dysbiosis.
Larsen PE; Dai Y
Gigascience; 2015; 4():42. PubMed ID: 26380076
[TBL] [Abstract][Full Text] [Related]
10. Metaproteomic and Metabolomic Approaches for Characterizing the Gut Microbiome.
Peters DL; Wang W; Zhang X; Ning Z; Mayne J; Figeys D
Proteomics; 2019 Aug; 19(16):e1800363. PubMed ID: 31321880
[TBL] [Abstract][Full Text] [Related]
11. Potential Immune-Microbiome Interactions in Breast Cancer May Advance Treatment: What's Holding Us Back?
Swafford AD; Khandelwal S; Bhute S
Crit Rev Immunol; 2021; 41(6):27-42. PubMed ID: 35695645
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Nandi D; Parida S; Sharma D
Gut Microbes; 2023; 15(1):2221452. PubMed ID: 37305949
[TBL] [Abstract][Full Text] [Related]
13. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients.
Cui X; Ye L; Li J; Jin L; Wang W; Li S; Bao M; Wu S; Li L; Geng B; Zhou X; Zhang J; Cai J
Sci Rep; 2018 Jan; 8(1):635. PubMed ID: 29330424
[TBL] [Abstract][Full Text] [Related]
14. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses.
Jaye K; Li CG; Bhuyan DJ
Crit Rev Oncol Hematol; 2021 Sep; 165():103429. PubMed ID: 34293459
[TBL] [Abstract][Full Text] [Related]
15. The Microbiome's Influence on Head and Neck Cancers.
Dorobisz K; Dorobisz T; ZatoĊski T
Curr Oncol Rep; 2023 Mar; 25(3):163-171. PubMed ID: 36696075
[TBL] [Abstract][Full Text] [Related]
16. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
17. The microbiome and breast cancer: a review.
Chen J; Douglass J; Prasath V; Neace M; Atrchian S; Manjili MH; Shokouhi S; Habibi M
Breast Cancer Res Treat; 2019 Dec; 178(3):493-496. PubMed ID: 31456069
[TBL] [Abstract][Full Text] [Related]
18. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer.
Megat Mohd Azlan PI; Chin SF; Low TY; Neoh HM; Jamal R
Proteomics; 2019 May; 19(10):e1800176. PubMed ID: 30557447
[TBL] [Abstract][Full Text] [Related]
19. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
Rao Malla R; Marni R; Kumari S; Chakraborty A; Lalitha P
Clin Breast Cancer; 2022 Apr; 22(3):200-211. PubMed ID: 34625387
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiome over a Lifetime and the Association with Hypertension.
Yano Y; Niiranen TJ
Curr Hypertens Rep; 2021 Mar; 23(3):15. PubMed ID: 33686539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
